Nephrology,
Journal Year:
2023,
Volume and Issue:
29(1), P. 5 - 17
Published: Sept. 4, 2023
Acute
kidney
injury
is
a
severe
disease
that
closely
associated
with
substantial
morbidity
and
mortality.
The
most
common
cause
of
AKI
renal
ischemia-reperfusion
injury.
Mesenchymal
stem
cells
(MSCs)
have
previously
been
shown
to
renoprotective
effects.
However,
extracellular
vesicles
secreted
by
MSCs
are
thought
be
the
key
for
therapeutic
effects
MSCs.
This
study
investigated
whether
small
EVs
derived
from
ACE2-modified
human
umbilical
cord
could
alleviate
RIRI
explored
their
underlying
molecular
mechanisms
METHODS:
A
lentivirus
carrying
an
ACE2
overexpression
vector
was
constructed
used
infect
were
isolated
MSC-conditioned
medium
ultracentrifugation.
HK-2
cocultured
MSC-ACE2-EVs
subjected
hypoxia/reoxygenation
MSCs-ACE2-EVs
injected
into
mice.
Biochemical
morphological
characteristics
assessed,
levels
inflammatory-related
factors,
oxidative
stress
products,
apoptosis
in
tissues
assessed
RESULTS:
In
vitro,
had
stronger
anti-inflammatory,
antioxidative
stress,
antiapoptotic
H/R
than
MSC-NC-EVs.
vivo,
target
injured
kidney,
reduce
blood
creatinine
urea
nitrogen
levels,
protect
I/R,
this
effect
may
related
activation
Nrf2/HO-1
signalling
pathway
CONCLUSION:
Taken
together,
our
results
demonstrated
MSC-ACE2-EVs,
which
protected
against
I/R
vitro
vivo.
agents
RIRI.
Cells,
Journal Year:
2023,
Volume and Issue:
12(9), P. 1293 - 1293
Published: May 1, 2023
Dyslipidemia
is
associated
with
endothelial
dysfunction.
Endothelial
dysfunction
the
initial
step
for
atherosclerosis,
resulting
in
cardiovascular
complications.
It
clinically
important
to
break
process
of
complications
patients
dyslipidemia.
Lipid-lowering
therapy
enables
improvement
function
likely
that
relationships
components
a
lipid
profile
such
as
low-density
lipoprotein
cholesterol,
high-density
cholesterol
and
triglycerides
are
not
simple.
In
this
review,
we
focus
on
roles
function.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(8), P. 923 - 923
Published: July 29, 2024
Oxidative
stress
plays
a
significant
role
in
the
pathogenesis
of
cardiovascular
diseases,
such
as
myocardial
ischemia/reperfusion
injury,
atherosclerosis,
heart
failure,
and
hypertension.
This
systematic
review
aims
to
integrate
most
relevant
studies
on
oxidative
management
diseases.
We
searched
literatures
PubMed
database
using
specific
keywords.
put
emphasis
those
manuscripts
that
were
published
more
recently
higher
impact
journals.
reviewed
total
200
articles.
examined
current
managements
including
supplements
like
resveratrol,
vitamins
C
E,
omega-3
fatty
acids,
flavonoids,
coenzyme-10,
which
have
shown
antioxidative
properties
potential
benefits.
In
addition,
we
pharmacological
treatments
newly
discovered
antioxidants
nanoparticles
show
effects
targeting
pathways.
Lastly,
biomarkers,
soluble
transferrin
receptor,
transthyretin,
cystatin
evaluating
antioxidant
status
identifying
risk.
By
addressing
mechanisms,
this
paper
emphasizes
importance
maintaining
balance
between
oxidants
progression
is
registered
with
International
Platform
Registered
Systematic
Review
Meta-analysis
Protocols
(INPLASY),
registration
#
INPLASY202470064.
Frontiers in Physiology,
Journal Year:
2022,
Volume and Issue:
13
Published: Aug. 30, 2022
Among
the
diseases
causing
human
death,
cardiovascular
disease
(CVD)
remains
number
one
according
to
World
Health
Organization
report
in
2021.
It
is
known
that
atherosclerosis
pathological
basis
of
CVD.
Low-density
lipoprotein
(LDL)
plays
a
pivotal
role
initiation
and
progression
atherosclerotic
CVD
(ASCVD).
LDL
cholesterol
(LDL-C)
traditional
biological
marker
LDL.
However,
large
numbers
patients
who
have
achieved
recommended
LDL-C
goals
still
ASCVD
risk.
In
multiple
prospective
studies,
particle
(LDL-P)
reported
be
more
accurate
predicting
risk
than
LDL-C.
LDL-Ps
differ
size,
density
chemical
composition.
Numerous
clinical
studies
proved
atherogenic
mechanisms
are
determined
not
only
by
size
but
also
modifications.
Of
note,
small
dense
(sdLDL)
particles
possess
stronger
ability
compared
with
intermediate
subfractions.
Besides,
oxidized
(ox-LDL)
another
factor
atherosclerosis.
lipid-lowering
drugs,
statins
induce
dramatic
reductions
LDL-P
lesser
extend.
Recently,
proprotein
convertase
subtilsin/kexin
type
9
inhibitors
(PCSK9i)
been
demonstrated
effective
lowering
levels
LDL-C,
LDL-P,
as
well
events.
this
article,
we
will
make
short
review
metabolism,
discuss
discordance
between
outline
action
focusing
on
sdLDL
ox-LDL,
summarize
methods
used
for
measurement
subclasses,
conclude
advances
LDL-lowering
therapies
using
PCSK9i.
Metabolism Open,
Journal Year:
2025,
Volume and Issue:
25, P. 100346 - 100346
Published: Jan. 5, 2025
Dyslipidemia
is
a
prominent
pathological
feature
responsible
for
oxidative
stress-induced
cardiac
damage.
Due
to
their
high
antioxidant
content,
dietary
compounds,
such
as
aspalathin
and
sulforaphane,
are
increasingly
explored
cardioprotective
effects
against
lipid-induced
toxicity.
Cultured
H9c2
cardiomyoblasts,
an
in
vitro
model
routinely
used
assess
the
pharmacological
effect
of
drugs,
were
pretreated
with
(1
μM)
sulforaphane
(10
before
exposure
palmitic
acid
(0.25
mM)
induce
lipidemic-related
complications.
The
results
showed
that
both
enhanced
cellular
metabolic
activity
improved
mitochondrial
respiration
correlating
mRNA
expression
genes
involved
function,
including
uncoupling
protein
2,
peroxisome
proliferator-activated
receptor,
gamma
coactivator
1-alpha,
nuclear
respiratory
factor
1,
ubiquinol-cytochrome
c
reductase
complex
assembly
1.
Beyond
attenuating
lipid
peroxidation,
compounds
also
suppressed
intracellular
reactive
oxygen
species
responses,
erythroid
2-related
2.
These
envisaged
benefits
associated
decreased
apoptosis.
This
preclinical
study
supports
warrants
further
investigation
into
potential
these
or
foods
rich
protecting
damage
within
myocardium.
Pharmacology Research & Perspectives,
Journal Year:
2025,
Volume and Issue:
13(1)
Published: Feb. 1, 2025
ABSTRACT
This
study
aimed
to
evaluate
the
anticonvulsant
properties
of
fenoprofen
on
experimental
model
pentylenetetrazole
(PTZ)‐induced
epilepsy.
Male
Wistar
rats
were
randomly
grouped
into
five,
and
kindling
was
induced
by
intraperitoneal
injection
PTZ
35
(mg/kg)
every
other
day
for
1
month.
Aside
from
control
groups,
three
groups
received
injections
at
doses
10,
20,
40
before
each
injection.
Rats
challenged
with
70
week
after
development.
Then
subjected
deep
anesthesia,
serum
brain
samples
prepared.
Oxidative
stress
(OS)
markers
(malondialdehyde,
superoxide
dismutase,
glutathione
peroxidase)
measured
in
samples.
Hippocampal
tissue
used
investigate
relative
expression
OS‐related
genes
(
nuclear
factor
[
erythroid‐derived
2
]‐
like
Nrf2
)/
heme
oxygenase
Hmox1
))
histological
studies.
Seizure
behavior
assessed
based
Lüttjohann's
score.
In
treated
number
myoclonic
jerks
generalized
tonic–clonic
seizure
(GTCS)
duration
decreased
significantly,
while
GTCS
latency
increased
compared
group.
The
biochemical
evaluation
revealed
antioxidative
effects
fenoprofen.
/
HO‐1
group
reversed
administration.
results
obtained
Nissl
staining
hippocampal
also
confirmed
protective
effect
seem
be
through
inhibition
markers,
induction
tissue,
activation
Nrf2/HO‐1
signaling
pathway.
Naunyn-Schmiedeberg s Archives of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 7, 2025
Abstract
This
research
investigated
the
hepatoprotective
effects
of
esomeprazole
(ESOM)
and
canagliflozin
(CANA)
against
methotrexate-induced
liver
toxicity,
focusing
on
AMPK
modulation
its
regulation
MAPK/JNK/ERK,
JAK1/STAT3,
PI3K/Akt
pathways.
Fifty
male
Wistar
rats
were
divided
into
five
groups:
control,
MTX,
three
pretreatment
groups
receiving
ESOM
(30
mg/kg),
CANA
or
their
combination.
administered
for
8
days
before
1
day
after
a
single
MTX
injection
(20
mg/kg,
intraperitoneally)
9
to
induce
hepatotoxicity.
Liver
injury,
oxidative
stress,
inflammation,
apoptosis
assessed
using
biochemical,
histopathological,
immunohistochemical,
qRT-PCR,
western
blot
analyses.
Data
analyzed
by
one-way
analysis
variance
(ANOVA)
Tukey’s
post
hoc
test,
with
significance
at
p
<
0.05.
Results
presented
as
mean
±
standard
error
(SE).
Rats
that
received
showed
significant
damage,
marked
elevated
ALT,
AST,
MDA,
MPO,
iNOS,
TNF-α,
IL-6,
IL-1β
levels
(
0.01)
decreased
antioxidant
enzymes
(HO-1,
Nrf2,
GSH).
Immunohistochemistry
revealed
increased
NF-kB
p65
caspase-9
expression
0.01),
correlating
histopathological
changes.
Pretreatment
reduced
enzyme
levels,
improved
histology,
restored
balance,
inhibited
inflammatory
pathways
via
p38MAPK/NF-kB
JAK1/STAT3
0.01).
Moreover,
preserved
activity
prevented
caspase-dependent
Additionally,
combination
treatment
synergistic
effects,
demonstrated
improvements
in
all
measured
parameters.
These
findings
suggested
had
potential
therapeutic
agents
alleviating
MTX-induced
hepatotoxicity
warranted
further
investigation
future
research.
Frontiers in Cell and Developmental Biology,
Journal Year:
2024,
Volume and Issue:
12
Published: June 10, 2024
This
comprehensive
review
inspects
the
therapeutic
potential
of
mesenchymal
stem
cell-derived
extracellular
vesicles
(MSC-EVs)
across
multiple
organ
systems.
Examining
their
impact
on
integumentary,
respiratory,
cardiovascular,
urinary,
and
skeletal
systems,
study
highlights
versatility
MSC-EVs
in
addressing
diverse
medical
conditions.
Key
pathways,
such
as
Nrf2/HO-1,
consistently
emerge
central
mediators
antioxidative
anti-inflammatory
effects.
From
expediting
diabetic
wound
healing
to
mitigating
oxidative
stress-induced
skin
injuries,
alleviating
acute
lung
even
offering
solutions
for
conditions
like
myocardial
infarction
renal
ischemia-reperfusion
injury,
demonstrate
promising
efficacy.
Their
adaptability
different
administration
routes
identifying
specific
factors
opens
avenues
innovative
regenerative
strategies.
positions
candidates
future
clinical
applications,
providing
a
overview
medicine.